rs766835582
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PM2PM5PP3_ModeratePP5_Very_Strong
The NM_152419.3(HGSNAT):c.1031G>A(p.Arg344His) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000192 in 1,613,752 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R344C) has been classified as Pathogenic.
Frequency
Consequence
NM_152419.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 14 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HGSNAT | NM_152419.3 | c.1031G>A | p.Arg344His | missense_variant | 11/18 | ENST00000379644.9 | NP_689632.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HGSNAT | ENST00000379644.9 | c.1031G>A | p.Arg344His | missense_variant | 11/18 | 2 | NM_152419.3 | ENSP00000368965.4 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152180Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000361 AC: 9AN: 249282Hom.: 0 AF XY: 0.0000444 AC XY: 6AN XY: 135242
GnomAD4 exome AF: 0.0000185 AC: 27AN: 1461572Hom.: 0 Cov.: 30 AF XY: 0.0000179 AC XY: 13AN XY: 727070
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152180Hom.: 0 Cov.: 31 AF XY: 0.0000269 AC XY: 2AN XY: 74340
ClinVar
Submissions by phenotype
Mucopolysaccharidosis, MPS-III-C Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Lifecell International Pvt. Ltd | - | A Homozygote Missense variant c.1031G>A in Exon 11 of the HGSNAT gene that results in the amino acid substitution p.Arg344His was identified. The observed variant has a maximum allele frequency of 0.00004/0.00003% in gnomAD exomes and genomes, respectively. The severity of the impact of this variant on the protein is medium, based on the effect of the protein and REVEL score . Rare Exome Variant Ensemble Learner (REVEL) is an ensembl method for predicting the pathogenicity of missense variants based on a combination of scores from 13 individual tools: MutPred, FATHMM v2.3, VEST 3.0, PolyPhen-2, SIFT, PROVEAN, MutationAssessor, MutationTaster, LRT, GERP++, SiPhy, phyloP, and phastCons. The REVEL score for an individual missense variant can range from 0 to 1, with higher scores reflecting greater likelihood that the variant is disease-causing. ClinVar has also classified this variant as Pathogenic/LikelyPathogenic(Variant ID 551378 ).This variant has been previously reported in Mathew F et al., 2009. Based on the above evidence this variant has been classified as Pathogenic according to the ACMG guidelines. - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Counsyl | Apr 05, 2017 | - - |
Mucopolysaccharidosis, MPS-III-C;C4225287:Retinitis pigmentosa 73 Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Sep 11, 2023 | This sequence change replaces arginine, which is basic and polar, with histidine, which is basic and polar, at codon 344 of the HGSNAT protein (p.Arg344His). This variant is present in population databases (rs766835582, gnomAD 0.02%). This missense change has been observed in individual(s) with mucopolysaccharidosis type III (PMID: 17033958). This variant is also known as c.1115G>A (p.R372H). ClinVar contains an entry for this variant (Variation ID: 551378). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt HGSNAT protein function. This variant disrupts the p.Arg344 amino acid residue in HGSNAT. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 17033958, 18024218). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. - |
not provided Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Dec 08, 2021 | Identified in a patient with mucopolysaccharidosis IIIC in the presence of a second HGSNAT variant of uncertain significance of unknown phase in published literature (Hrebicek M et al., 2006); Published functional studies demonstrate reduced enzyme activity with a misfolded and abnormally glycosylated protein that was not targeted to the lysosome and instead retained in the endoplasmic reticulum (Feldhammer M et al., 2009); This variant is associated with the following publications: (PMID: 27491071, 17033958, 19823584, 19479962) - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at